IFNG and COVID-19: Here, we evaluated the level of SARS-CoV-2-specific IFN-γ producing bulk T cells in the COVID-19 patients, following stimulation with overlapping peptides covering the spike (containing the immunodominant sequence domains of spike), spike+ (containing a portion of the spike region) and the nucleocapsid (covering full sequence) proteins (Figure 6).